baber/WOPTO huggingface dataset:
Patent EA-000114-B1 (EA)
Title: A bottle having a handle and a method of forming the bottle by stretch blow molding
Inventor: TAKEUCHI SETSUYUKI
IPC: B29C49/08
Filed: 1996-11-26
Abstract: There is provided a bottle having a handle formed by stretch blow molding comprising an improved structure and facilitates carrying even a relatively large bottle in which a bendable handle having a flat shape extending in a transverse direction is integrally formed below a threaded portion of a neck of the bottle on the bottle, and a connecting portion of said handle includes a narrow portion which is transversally provided by reducing the thickness at an intermediate portion of the connecting portion, whereby making the finger engaging tab bendable at the narrow portion in upper and lower directions, and molecular orientation of the resin material is performed by the narrow portion. <IMAGE>
Patent EA-004160-B1 (EA)
Title: Intrinsically bactericidal absorbent dressing and method of fabrication
Inventor: BATICH CHRISTOPHER D
IPC: A61F5/441
Filed: 1999-12-08
Abstract: 1. A dressing for absorbing biological fluids, comprising a superabsorbent polymer matrix having an enhanced surface area wherein said surface area is enhanced by addition of polymeric chains length, sufficient for enhancing of surface area of basic matrix, to which said polymer; and a plurality of antimicrobial compounds coupled by non-siloxane or any other covalent bonds carbon-carbon or carbon-oxygen to said polymer matrix, said bonds being stable when reacting with an acid or alkali. 2. A dressing as recited in claim 1, wherein said plurality of antimicrobial compounds comprise quaternary ammonium compounds. 3. A dressing as recited in claim 1, wherein said antimicrobial compounds comprise chain-like structures tethered at one to said polymer matrix. 4. A dressing as recited in claim 1, wherein said plurality of antimicrobial compounds are non-ionic compounds. 5. A dressing as recited in claim 1, wherein said dressing comprises a sanitary pad. 6. A dressing as recited in claim 1, wherein said dressing comprises a tampon. 7. A dressing as recited in claim 1, wherein said dressing comprises a bandage. 8. A method for fabricating an intrinsically antimicrobial absorbent dressing, comprising the steps of forming a superabsorbent synthetic polymer matrix having an enhanced surface area, wherein said surface area is enhanced by addition of polymeric chains length, sufficient for enhancing of surface area of basic matrix, to which said polymer; and a plurality of antimicrobial compounds coupled by non-siloxane or any other covalent bonds carbon-carbon or carbon-oxygen to said polymer matrix, said bonds being stable when reacting with an acid or alkali; and attaching a plurality of antimicrobial compound to the enhanced surface area of said polymer matrix.
Patent EA-006107-B1 (EA)
Title: Substituted bicyclic derivatives as anticancer agents
Inventor: KATH JOHN CHARLES
IPC: C07D215/38
Filed: 1999-12-06
Abstract: The invention relates to compounds of formula (1) and to pharmaceutically acceptable salts and solvates thereof, wherein A, X, R<1>, R<3> and R<4> are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals with administering the compounds of formula (1) and to pharmaceutical compositions for treating such disorders which contain the compounds of formula (1). The invention also relates to methods of preparing the compounds of formula (1).
Patent EA-006843-B1 (EA)
Title: Water-like fluid for consumption by humans or animals instead of water
Inventor: STILLMAN SUZANNE JAFFE
IPC: A23L1/308
Filed: 2001-02-22
Abstract: A water-like fluid containing safe water and a significant quantity of soluble dietary fiber. The resulting solution is generally optically clear and has physical properties similar to potable water. The fluid is intended as a replacement for bottled, or other water, as a means to ensure proper hydration. Depending on the soluble fiber used the fluid is either non-caloric or extremely low in calories. The amount of soluble fiber is adjusted to a specific amount of water so that consumption of an adequate amount of fluid ensures hydration (e.g., eight 8 oz. glasses per day) will also providing an optimal amount of dietary fiber. This is particularly valuable in stressed situations where the diet may not provide adequate fiber without supplementation. The constant metered supply of fiber provided throughout the day is preferable to, and more convenient than, "bolus" administration of fiber through laxatives, etc. Additionally, the constant presence of soluble fiber in the digestive tract provides the known beneficial effects of moderating the postprandial increase in blood glucose, modulating serum lipid levels, and suppressing appetite.
Patent EA-005179-B1 (EA)
Title: Stable pharmaceutical solution formulations for pressurised metered dose inhalers
Inventor: LEWIS DAVID
IPC: A61L9/04
Filed: 2000-05-22
Abstract: 1. An aerosol composition which comprises an amino type drug bearing a functional group sensitive to oxidative and/or hydrolytic reaction in a solution of a liquefied HFA propellant, a co-solvent selected from pharmaceutically acceptable alcohols, wherein the pH of the solution has been adjusted to between 2.5 and 5.0 by addition of small amounts of a mineral acid such as hydrochloric, nitric or phosphoric acid. 2. A composition according to claim 1, wherein the pH of the solution has been adjusted between 3.0 and 3.5. 3. A composition according to claims 1-2, wherein the solution includes a low volatility component with a vapour pressure at 25 degree C not more than 0.1 kPa, preferably not more than 0.05 kPa. 4. A composition according to any preceding claim, wherein the solution includes at least 0.2% by weight of the low volatility component and not more than 10% by weight. 5. A composition according to claims 1-4, wherein the cosolvent is an alcohol, preferably ethanol. 6. A composition according to claims 3-5, wherein the low volatility component is selected from a glycol or an ester. 7. A composition according to claim 6, wherein the low volatility component is isopropyl myristate. 8. A composition according to any preceding claim, wherein the propellant includes one or more HFAs selected from the group comprising HFA 134a and HFA 227. 9. A composition according to any preceding claim wherein the active ingredient is ass2-agonist selected from salbutamol, formoterol, salmeterol and TA-2005, salts thereof or their combination with steroid such as beclomethasone dipropionate, fluticasone propionate, budesonide and its 22R-epimer. 10. A pressurised metered dose inhaler for aerosol administration consisting of a container having part or all of its internal metallic surfaces made of stainless steel, anodised aluminium or lined with an inert organic coating, containing a composition according to claims 1-9. 11. A method of filling the inhaler of claim 10, the method comprising: (a) preparation of a solution of one or more active ingredients in one or more co-solvents optionally containing an appropriate amount of a low volatility component; (b) filling the device with said solution; (c) adding a pre-determined amount of a strong mineral acid; (d) adding a propellant containing a hydrofluoroalkane (HFA); (e) crimping with valves and gassing.
Patent EA-006687-B1 (EA)
Title: Arylmethylamine derivatives for use as tryptase inhibitors
Inventor: ASTLES PETER C
IPC: A61K31/453
Filed: 2001-04-27
Abstract: Provided herein are compounds of formula (I)wherein R1-4, n and Ar are as defined in claim 1, and their pharmaceutical compositions. These compounds are tryptase inhibitors and may be used in the treatment of e.g. asthma and inflammatory diseases.
Patent EA-007430-B1 (EA)
Title: Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
Inventor: AMICI RAFAELLA
IPC: C07D417/12
Filed: 2002-09-19
Abstract: Compounds which are 3-aminoindazole derivatives or pharmaceutically acceptable salts thereof, together with pharmaceutical compositions comprising them are disclosed; these compounds or compositions are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.
Patent EA-008148-B1 (EA)
Title: New compounds, their use and preparation
Inventor: NILSSON BOJRN
IPC: C07D241/20
Filed: 2003-06-18
Abstract: The invention relates to compounds of the general Formula (I). The compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from a serotonin-related disorder. The invention also relates to such use as well as to pharmaceutical compositions comprising a compound of Formula (I).
Patent EA-010002-B1 (EA)
Title: Two stage hydrocarbon conversion reaction system and method of converting thereof
Inventor: SMITH JEFFREY S
IPC: C10G3/00
Filed: 2003-05-22
Abstract: This invention is to a method and system for operating a hydrocarbon conversion process. A two stage reactor system is used in which the gas superficial velocity of the second reaction stage is greater than that in the first reaction stage. The first reaction stage operates at more continuous stirred tank reactor (CSTR) like characteristics, and the second reaction stage operates at more plug flow reactor (PFR) like characteristics.
Patent EA-010759-B1 (EA)
Title: Methods of increasing platelet and hematopoietic stem cell production
Inventor: KAUSHANSKY KENNETH
IPC: C12N5/06
Filed: 2003-09-18
Abstract: A method of increasing hematopoietic stem cell production is disclosed. A method of reducing a time to engraftment following reinfusion of hematopoietic stem cells is also disclosed. The method includes administering a TPO mimetic compound to a subject.
Patent EA-008731-B1 (EA)
Title: A syringe for powder medicament premixing
Inventor: MU LIMIN
IPC: A61M5/315
Filed: 2004-08-10
Abstract: The present invention is directed to an assembled syringe for administer powder medicament in the field of medicine. According to the present invention, by using a connecting tube (14), a solvent bottle (8) contained with diluent is communicated with a solute bottle (10) contained with powder by the external force, and the diluent is injected into the solute bottle (10) through the connecting tube (14) under the effect of the pressure, after the powder is dissolved and mixed uniformly, the mixed solution is injected directly into a patient or added to a transfusion bottle or a transfusion tube. Both the solvent bottle (8) and the solute bottle (10) are packaged into a sleeve (5) to avoid being contaminated or cross-infection. Buckles (3) on the plunger sleeve (2) are fitted into restricting slots (4) on the sleeve (5), the fitting of the restricting slots (4) and buckles (3) allows the syringe to have the function of restricting the position, self-locking, controlling the magnitude of the force by which the solute bottle (10) is communicated with the solvent bottle (8), and being convenient for controlling the depth of the needle into the body, and to prevent misoperation or damage during transports, fetching and using. The present invention is a novel design with industrial applicability and inventive step and is adapted to be applied and generalized widely in the industries.
Patent EA-010112-B1 (EA)
Title: Hydrotreating catalyst containing a group v metal
Inventor: EIJSBOUTS SONJA
IPC: B01J23/887
Filed: 2005-04-19
Abstract: The present invention pertains to a sulfur-containing catalyst composition suitable for the hydrotreating of hydrocarbon feeds which comprises a Group VIB metal component selected from molybdenum, tungsten, and mixtures thereof, a Group V metal component selected from vanadium, niobium, tantalum, and mixtures thereof, and a Group VIII metal component selected from nickel, cobalt, iron, and mixtures thereof, the metal components (calculated as oxides) making up at least 50 wt.% of the catalyst, wherein the molar ratio between the metal components satisfies the following formula: (Group VIB + Group V):(Group VIII) = 0.5-2:1. This catalyst has been found to show a high activity in sulfur removal in combination with good aromatics removal properties.
Patent EA-010679-B1 (EA)
Title: Process for the manufacture of a bleaching agent
Inventor: POWELL DUANE J
IPC: B01F23/00
Filed: 2005-07-12
Abstract: A process and apparatus for the manufacture of high-strength, low-salt hypochlorite, especially sodium hypochlorite. An aqueous solution that comprises certain weight percentages of sodium hypochlorite and sodium hydroxide and that is essentially free of sodium chloride (salt) crystals, an aqueous solution that comprises a certain weight percentage of sodium hydroxide, and chlorine in gas and/or liquid phase that may or may not include inerts are reacted in a tank. This creates a solution having a precipitation zone where salt crystals are precipitating out of solution and falling downward to form a slurry, some of which is withdrawn, then cooled, and then re-introduced into the precipitation zone.; Above the precipitation zone is a crystal-free mother liquor zone consisting essentially of crystal-free mother liquor containing a weight percentage of sodium hypochlorite greater than that of than the lower strength aqueous sodium hypochlorite bleach being reacted.
Patent EA-013300-B1 (EA)
Title: Method system and program storage device for automatically calculating and displaying time and cost in a well planning system using a monte carlo simulation software
Inventor: GIVENS KRIS
IPC: G06Q10/00
Filed: 2005-08-23
Abstract: A method of generating and displaying time and cost data representing the time and the cost to complete a plurality of oilfield related activities in response to a set of engineering results including wellbore geometry and drilling parameters comprises the steps of: (a) assembling a plurality of time data and a plurality of cost data based on the engineering results in response to a plurality of activity templates; and (b) generating a display of the time data and the cost data, the display illustrating the time data and the cost data representing the time and the cost to complete the plurality of oilfield related activities. The display includes a numerical display and a graphical display.
Patent EA-009205-B1 (EA)
Title: Lost circulation additive for drilling fluid
Inventor: WAY PAUL
IPC: C09K8/035
Filed: 2005-10-13
Abstract: Additive for a drilling fluid to block drilling-induced or pre-existing rock fractures comprising polymeric granules with a diameter distribution peak between 1000 and 200 microns and an average resiliency of at least 10 % rebound after compression by a load of 200 N and uses thereof.
Patent EA-012372-B1 (EA)
Title: Special effect paint set
Inventor: FRERA LAURA
IPC: C09D7/80
Filed: 2005-11-24
Abstract: The invention relates to a special effect paint set and its use. The set contains water-based paint components for forming a water-based paint at the point of sale, distribution or application and includes at least a binder paint component. The set further includes a thickener paint component and at least one special effect paint component containing a special effect pigment.
Patent EA-012892-B1 (EA)
Title: Wellbore cleaning tool for cleaning ferrous material and method therefor
Inventor: TELFER GEORGE
IPC: E21B37/00
Filed: 2006-05-11
Abstract: There is disclosed a cleaning tool for use in cleaning ferrous material from a wellbore, a cleaning assembly comprising a tool main body and, at least, one magnet mounted for selective movement relative to the main body between deactivated and activated positions and held in the deactivated position radially inside relative to the tool main body and in the activated position radially outside relative to the tool main body. An assembly for use in cleaning ferrous material from a wellbore comprises a plurality of such wellbore cleaning tools. A drilling or milling string comprises a drilling or milling tool and a cleaning tool. A method of cleaning ferrous material from a wellbore, the method comprising the steps of: running a cleaning tool into a wellbore to be cleaned with a magnet of the cleaning tool in a deactivated position; moving the magnet from the deactivated position to an activated position by moving it radially outside relative to the main body; and translating the cleaning tool relative to the wellbore to collect ferrous material present in the wellbore.
Patent EA-014783-B1 (EA)
Title: Dna binding site of a transcriptional activator useful in gene expression
Inventor: PARENICOVA LUCIE
IPC: C12N15/80
Filed: 2006-10-24
Abstract: We have discovered DNA binding sites which are specifically recognized by PrtT, a transcriptional activator for protease genes. The DNA binding site can be defined structurally by a consensus nucleotide sequence and functionally by PrtT's ability to regulate transcriptional activation through that sequence. Both PrtT and its cognate DNA binding site (i.e., the nucleotide sequence in each promoter that is recognized by PrtT) can be used in a gene expression system. Possession of only a PrtT transcriptional activator is insufficient, its cognate DNA binding site is necessary for recognition by PrtT (i.e., binding to the site and activating transcription under appropriate conditions). A functional site, such as one obtained from a wild-type fungal gene, will confer PrtT- dependent transcriptional activation on 3'-downstream sequences.; A mutation of a wild- type promoter that results in a non-functional site will abolish PrtT-dependent transcriptional activation of 3'-downstream sequences. A mutation of a wild-type promoter that results in a more functional site will enhance PrtT-dependent transcriptional activation of 3'-downstream sequences.
Patent EA-017621-B1 (EA)
Title: Plant productivity enhancement by combining chemical agents with transgenic modifications
Inventor: VOESTE DIRK
IPC: A01N43/56
Filed: 2008-04-23
Abstract: The present invention relates to the enhancement of plant productivity by combining chemical agents with transgenic modifications.
Patent EA-016798-B1 (EA)
Title: Novel crystalline form of 3-(difluoromethyl)-1-methyl-n-(3',4',5'-trifluor[1,1'-biphenyl]-2-yl)-1h-pyrazol-4-carboxamide
Inventor: SAXELL HEIDI EMILIA
IPC: A01N43/56
Filed: 2008-07-07
Abstract: The present invention relates to a new crystalline form of 3-(difluormethyl)-1-methyl-N-(3',4',5'-trifluor[1,1'-biphenyl]-2-yl)-1H-pyrazol-4-carboxamide. The invention also relates to processes for the production of this crystalline form and formulations for plant protection which contain the crystalline form of 3-(difluormethyl)-1-methyl-N-(3',4',5'-trifluor[1,1'-biphenyl]-2-yl)-1H-pyrazol-4-carboxamide.
Patent EA-020659-B1 (EA)
Title: 1'-substituted carba-nucleoside analogs for antiviral treatment
Inventor: BUTLER THOMAS
IPC: C07H19/23
Filed: 2009-04-22
Abstract: Provided are compounds of general formula Ior pharmaceutically acceptable salts thereof, and also pharmaceutical compositions containing such compounds. In particular, provided are pyrrolo[1,2-f][1,2,4]triazinyl, imidazo[1,5-f][1,2,4]triazinyl, imidazo[1,2-f][1,2,4]triazinyl, and [1,2,4]triazolo[4,3-f][1,2,4]triazinyl nucleosides, and also nucleoside phosphates and prodrugs thereof, wherein the 1' position of the nucleoside sugar is substituted. A method of treating a viral infection and a method of inhibiting HCV polymerase by administering compounds of formula I are also proposed. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C virus infections.
Patent EA-020754-B1 (EA)
Title: Absorbent and method for removing acid gas from fluid stream
Inventor: VORBERG GERALD
IPC: B01D53/14
Filed: 2010-05-12
Abstract: An absorbent for removing acid gases from a fluid flow comprises an aqueous solution of: a) at least one amine, comprising at least one amine having solely tertiary and/or sterically hindered amino groups, and b) at least one organic phosphonic acid selected from phosphonic acids of formula IIwhere R' is H or C-alkyl, Q is H, OH or NYand Y is H or CHPOH, or a mixture of two or more thereof, wherein the molar ratio of b) to a) ranges between 0.01 and 0.1, and also a process for the removal of acid gases from a fluid stream. For example, the phosphonic acid is 1-hydroxyethane-1,1-diphosphonic acid. Compared to absorbents based on amines or amine/promoter combinations, the absorbent requires less regeneration energy without substantially reducing the solution's capacity to absorb acid gases.
Patent EA-022007-B1 (EA)
Title: Heterocylcic derivatives as inhibitors of glutaminyl cyclase
Inventor: HEISER ULRICH
IPC: C07D471/14
Filed: 2010-09-13
Abstract: The present invention relates to novel pyrrolidine derivatives of formula (I), wherein R, Rand Rare as defined herein, as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N-terminal glutamine residues into pyroglutamic acid (5-oxoprolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water.
Patent EA-020181-B1 (EA)
Title: Water purification device
Inventor: CHATTERJEE JAIDEEP
IPC: C02F1/00
Filed: 2010-09-03
Abstract: The invention relates to a water purification device and a process for water purification and in particular relates to a water purification device that maybe used as a gravity fed system or adapted to be connected to the main water supply. It is a single chamber water purification device which is capable of dosing a controlled level of a biocide to the water and has a filtration unit that functions as a filter-cum-scavenger. This water purification device provides several advantages over the prior art especially in terms of reducing the complexity of the device thus making it economical and reducing the number of replaceable parts without affecting the performance in terms of microbial safety or flow rate. Another advantage of the system is that it can be adapted for use with solid and liquid biocides.
Patent EA-026384-B1 (EA)
Title: Treatment of cardiac conditions
Inventor: PETERSEN JOERGEN SOEBERG
IPC: A61P9/04
Filed: 2011-01-20
Abstract: The invention relates to the treatment of cardiac dysfunction. In particular, certain compounds, believed to be glucagon-GLP-1 dual agonist compounds, exert a positive inotropic effect while preserving the energy balance of the heart, and so may be superior to known inotropic agents such as dobutamine, norepinephrine and glucagon.
Patent EA-022295-B1 (EA)
Title: High reflection glass panel
Inventor: DUSOULIER LAURENT
IPC: C03C17/34
Filed: 2011-03-09
Abstract: The invention relates to a glass panel including at least two layers deposited by cathode sputtering, including at least one layer of a metal oxide, suboxide, nitride or oxynitride having a refractive index which is not lower than 2.2 and, stacked directly or indirectly on top of said layer, at least one layer consisting of mixed oxides of titanium and at least one other metal, said mixed oxides having a weight proportion of titanium oxide which is not less than 40% and not greater than 95%, the thickness of the layer in question and that of the other layer(s) having a refractive index greater than 2.2 being selected such that, on a 4-mm thick sheet of clear "float" glass, said layer(s) result(s) in a reflection of at least 15% and a light transmission of at least 60%, the layer or system of layers in question further having a mechanical and/or chemical resistance comparable to those of layers produced by pyrolysis for obtaining products having the same type of optical properties.